Citigroup Inc Biotechnology

Citigroup Inc

$190 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALXO Alx Oncology Holdings Inc	$19.6M	$15,000 0.0% of portfolio	24,711	Q1 2025 Reduced 21.39%
IPSC Century Therapeutics, Inc.	$34.2M	$15,000 0.0% of portfolio	32,859	Q1 2025 Reduced 8.96%
TARA Protara Therapeutics, Inc.	$37.5M	$15,000 0.0% of portfolio	3,639	Q1 2025 Reduced 71.89%
GBIO Generation Bio Co.	$252M	$13,000 0.0% of portfolio	34,787	Q1 2025 Reduced 16.13%
IGMS Igm Biosciences, Inc.	$36.8M	$13,000 0.0% of portfolio	11,714	Q1 2025 Reduced 4.38%
OVID Ovid Therapeutics Inc.	$47.9M	$13,000 0.0% of portfolio	43,197	Q1 2025 Reduced 11.03%
GOSS Gossamer Bio, Inc.	$162M	$11,000 0.0% of portfolio	10,678	Q1 2025 Added 355,833.34%
NVCT Nuvectis Pharma, Inc.	$118M	$10,000 0.0% of portfolio	1,025	Q1 2025 New
RZLT Rezolute, Inc.	$209M	$10,000 0.0% of portfolio	3,638	Q1 2025 Reduced 95.74%
ABCL Ab Cellera Biologics Inc.	$1.4B	$9,000 0.0% of portfolio	4,337	Q1 2025 Reduced 65.62%
PHVS Pharvaris N.V.	$781M	$8,000 0.0% of portfolio	543	Q4 2024 New
GALT Galectin Therapeutics Inc	$165M	$8,000 0.0% of portfolio	6,607	Q1 2025 Reduced 58.9%
IMTX Immatics N.V.	$453M	$7,000 0.0% of portfolio	1,758	Q1 2025 Reduced 5.53%
PRLD Prelude Therapeutics Inc	$30.9M	$7,000 0.0% of portfolio	9,300	Q1 2025 Reduced 8.96%
BCYC Bicycle Therapeutics PLC	$248M	$5,000 0.0% of portfolio	689	Q1 2025 Added 9.37%
PLX Protalix Bio Therapeutics, Inc.	$77.1M	$5,000 0.0% of portfolio	2,292	Q1 2025 Added 262.66%
AUTL Autolus Therapeutics PLC	$237M	$4,000 0.0% of portfolio	3,163	Q1 2025 Reduced 5.02%
CRVS Corvus Pharmaceuticals, Inc.	$209M	$4,000 0.0% of portfolio	1,521	Q1 2025 Reduced 96.85%
LYRA Lyra Therapeutics, Inc.	$255M	$4,000 0.0% of portfolio	35,177	Q1 2025 Reduced 7.68%
SPRB Spruce Biosciences, Inc.	$2.83M	$3,000 0.0% of portfolio	11,083	Q1 2025 New
ACIU Ac Immune Sa	$193M	$2,000 0.0% of portfolio	1,439	Q1 2025 Reduced 47.23%
IFRX Infla Rx N.V.	$37.1M	$1,000 0.0% of portfolio	1,301	Q2 2024 Reduced 99.89%
ACET Adicet Bio, Inc.	$30M	$1,000 0.0% of portfolio	2,290	Q1 2025 Added 846.28%
IMRX Immuneering Corp	$111M	$1,000 0.0% of portfolio	796	Q1 2025 Reduced 65.35%
SILO Silo Pharma, Inc.	$1.98M	$1,000 0.0% of portfolio	1,532	Q1 2025 Reduced 43.07%
AADI Aadi Bioscience, Inc.	$35.9M	$0 0.0% of portfolio	75	Q4 2024 Reduced 7.41%
LIFE A Tyr Pharma Inc	$53.2M	$0 0.0% of portfolio	1	Q1 2025 Reduced 100.0%
ALLK Allakos Inc.	$28M	$0 0.0% of portfolio	16	Q1 2025 Reduced 40.74%
BLTE Belite Bio, Inc	$1.5B	$0 0.0% of portfolio	3	Q1 2025 New
ETON Eton Pharmaceuticals, Inc.	$360M	$0 0.0% of portfolio	1	Q1 2025 Reduced 100.0%
IMAB I Mab	$173M	$0 0.0% of portfolio	50	Q4 2023 Reduced 94.55%
IPA Immuno Precise Antibodies Ltd.	$40.5M	$0 0.0% of portfolio	7	Q3 2021 New
KRON Kronos Bio, Inc.	$50M	$0 0.0% of portfolio	1,078	Q1 2025 New
MIST Milestone Pharmaceuticals Inc.	$46.2M	$0 0.0% of portfolio	2	Q1 2025 Reduced 99.39%
NBTX Nanobiotix S.A.	$196M	$0 0.0% of portfolio	241	Q4 2024 Reduced 92.96%
RANI Rani Therapeutics Holdings, Inc.	$10.8M	$0 0.0% of portfolio	313	Q1 2025 New
RLMD Relmada Therapeutics, Inc.	$18M	$0 0.0% of portfolio	2	Q1 2025 Reduced 100.0%
SNSE Sensei Biotherapeutics, Inc.	$237M	$0 0.0% of portfolio	124	Q1 2025 New
MCRB Seres Therapeutics, Inc.	$1.54B	$0 0.0% of portfolio	215	Q1 2025 Reduced 94.16%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	95,210	Q1 2025 Reduced 5.44%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.